No evidence for occult HBV infection in hepatitis B vaccine non-responders

被引:0
作者
Aghasadeghi, Mohammad Reza [1 ]
Banifazl, Mohammad [2 ]
Aghakhani, Arezoo [3 ]
Eslamifar, Ali [3 ]
Vahabpour, Rouhollah [1 ]
Ramezani, Amitis [3 ]
机构
[1] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran
[2] Iranian Soc Support Patients Infect Dis, Tehran, Iran
[3] Pasteur Inst Iran, Clin Res Dept, 69 Pasteur Ave, Tehran 13164, Iran
关键词
HBV; HBV core antibody; HBV vaccine non-responders; Occult HBV infection;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background and Objective: Although hepatitis B vaccine immunogenicity is high, certain risk factors such as age, tobacco consumption, obesity and genetic background have been associated with low responsiveness to HBV vaccine. We aimed to evaluate the role of occult hepatitis B virus (HBV) infection in non-responder adults to HBV vaccine in a low endemic area for HBV. Material and Methods: A total of 52 subjects who were non-responder to HBV vaccine were enrolled in the study. HBsAg, anti-HBs and anti-HBc were tested in all subjects. The presence of HBV-DNA was determined in plasma samples by real-time PCR. Results: A total of 52 cases with median age 34 years were enrolled in the study. 63.5% of patients were male and 36.5% were female. Isolated anti-HBc (HBsAg negative, anti-HBs negative and anti-HBc positive) was detected in 3.8% of cases. HBV-DNA was not detected in our cases. Conclusion: This study showed no evidence of occult HBV infection in our HBV vaccine non-responders even in cases with isolated anti-HBc.
引用
收藏
页码:350 / 353
页数:4
相关论文
共 35 条
  • [1] Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for Consideration
    Aghakhani, Arezoo
    Banifazl, Mohammad
    Velayati, Ali Akbar
    Eslamifar, Ali
    Ramezani, Amitis
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2012, 16 (04) : 328 - 333
  • [2] Alavian SM, 2007, J GASTROINTEST LIVER, V16, P403
  • [3] Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody
    Azadmanesh, Kayhan
    Mohraz, Minoo
    Aghakhani, Arezoo
    Edalat, Rozita
    Jam, Sara
    Eslamifar, Ali
    Banifazl, Mohammad
    Moradmand-Badie, Banafsheh
    Ramezani, Amitis
    [J]. INTERVIROLOGY, 2008, 51 (04) : 270 - 274
  • [4] Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"?
    Bréchot, C
    Thiers, V
    Kremsdorf, D
    Nalpas, B
    Pol, S
    Paterlini-Bréchot, P
    [J]. HEPATOLOGY, 2001, 34 (01) : 194 - 203
  • [5] Management of Chronic Hepatitis B in Pregnancy
    Buchanan, Corinne
    Tran, Tram T.
    [J]. CLINICS IN LIVER DISEASE, 2010, 14 (03) : 495 - +
  • [6] Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants
    Chang, Mei-Hwei
    [J]. ANTIVIRAL THERAPY, 2010, 15 (03) : 463 - 469
  • [7] Detecting hepatitis B surface antigen mutants
    Coleman, PF
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (02) : 198 - 203
  • [8] Occult hepatitis B virus infection: A hidden menace?
    Conjeevaram, H
    Lok, AS
    [J]. HEPATOLOGY, 2001, 34 (01) : 204 - 206
  • [9] Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen
    Cooreman, MP
    Leroux-Roels, G
    Paulij, WP
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (03) : 237 - 247
  • [10] The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation
    Goncalves, L
    Albarran, B
    Salmen, S
    Borges, L
    Fields, H
    Montes, H
    Soyano, A
    Diaz, Y
    Berrueta, L
    [J]. VIROLOGY, 2004, 326 (01) : 20 - 28